13F Filings History of Cormorant Asset Management, LP
- Latest 13F filing
- Q1 2026 - 15 May 2026
- Latest reported 13F value
- $1,983,591,371
- Largest 13F holdings
-
PRAX BBOT EYPT EWTX ERAS RAPP ALMS ABVX MLTX DNTH DRUG BBIO
+8 more
OLMA BIOA CNTA DMRA MBX INSM NAMS TNGX - Notable people
- Bihua Chen
- Form 13F summary
-
- Cormorant Asset Management, LP Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- Cormorant Asset Management, LP reported 46 equity holdings with a total reported market value of $1,983,591,371 for Q1 2026. Top reported holdings included PRAX, BBOT, EYPT, EWTX, and ERAS.
- Manager signature
- Neb Obradovic - CCO
- Manager location
- Boston, MA
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Cormorant Asset Management, LP with Pro and return when a new 13F portfolio filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
Holdings Value
Form 13F evidence
Quarterly portfolio filings
SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.
Latest quarter
Q1 2026
Latest value
$1,983,591,371
Quarter delta
+$219,598,594
Accepted
15 May 2026, 12:43
Rows shown
1-25 of 50
| Quarter | Holdings | SEC-reported value | Bought | Sold | Net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | 46 | $1,983,591,371 | +$464,508,908 | -$219,040,905 | +$245,468,003 | PRAX, BBOT, EYPT, EWTX, ERAS | 13F-HR | 15 May 2026, 12:43 |
| Q4 2025 | 32 | $1,763,992,777 | +$158,850,176 | -$423,997,347 | -$265,147,171 | PRAX, BBOT, ABVX, EYPT, RAPP | 13F-HR | 17 Feb 2026, 15:00 |
| Q3 2025 | 36 | $1,449,259,159 | +$245,102,267 | -$329,747,223 | -$84,644,956 | BBOT, ABVX, EYPT, RAPP, BBIO | 13F-HR | 14 Nov 2025, 13:03 |
| Q2 2025 | 42 | $1,342,486,545 | +$67,487,014 | -$136,202,714 | -$68,715,700 | MLTX, EYPT, BBIO, PRAX, MRUS | 13F-HR | 14 Aug 2025, 15:36 |
| Q1 2025 | 42 | $1,320,779,265 | +$97,067,604 | -$172,937,613 | -$75,870,009 | MLTX, EWTX, BBIO, ACLX, PRAX | 13F-HR | 15 May 2025, 15:22 |
| Q4 2024 | 48 | $1,820,860,799 | +$260,915,006 | -$240,111,402 | +$20,803,604 | MLTX, PRAX, JANX, ACLX, EWTX | 13F-HR | 14 Feb 2025, 15:01 |
| Q3 2024 | 45 | $1,885,759,705 | +$142,082,984 | -$157,326,566 | -$15,243,582 | MLTX, PCVX, ACLX, LBPH, EWTX | 13F-HR | 14 Nov 2024, 15:11 |
| Q2 2024 | 47 | $1,719,391,869 | +$351,015,509 | -$590,590,808 | -$239,575,299 | MLTX, CRBP, ACLX, PCVX, LBPH | 13F-HR | 14 Aug 2024, 15:05 |
| Q1 2024 | 56 | $2,269,736,201 | +$568,656,118 | -$503,532,849 | +$65,123,269 | MLTX, EYPT, ACLX, ALPN, BBIO | 13F-HR | 15 May 2024, 15:22 |
| Q4 2023 | 47 | $2,088,803,226 | +$533,536,505 | -$613,037,468 | -$79,500,963 | MLTX, AMAM, EYPT, BBIO, ACLX | 13F-HR | 14 Feb 2024, 15:11 |
| Q3 2023 | 49 | $1,714,347,327 | +$289,854,336 | -$253,414,793 | +$36,439,543 | MLTX, BBIO, AMAM, ACLX, APLS | 13F-HR | 14 Nov 2023, 15:25 |
| Q2 2023 | 61 | $1,755,848,549 | +$300,200,368 | -$426,182,392 | -$125,982,024 | MLTX, AMAM, APLS, BMEA, BBIO | 13F-HR | 14 Aug 2023, 15:19 |
| Q1 2023 | 72 | $1,518,444,000 | +$318,532,243 | -$333,894,509 | -$15,362,266 | RXDX, MLTX, BMEA, APLS, AMAM | 13F-HR | 15 May 2023, 15:34 |
| Q4 2022 | 72 | $1,487,868,000 | +$180,863,334 | -$213,052,472 | -$32,189,138 | RXDX, APLS, ACLX, MLTX, RNA | 13F-HR | 14 Feb 2023, 15:17 |
| Q3 2022 | 72 | $1,421,730,000 | +$267,756,231 | -$365,324,703 | -$97,568,472 | RXDX, APLS, DSGN, ERAS, ACLX | 13F-HR | 14 Nov 2022, 15:23 |
| Q2 2022 | 79 | $1,289,141,000 | +$253,118,894 | -$183,372,452 | +$69,746,442 | TPTX, DSGN, ERAS, RXDX, APLS | 13F-HR | 15 Aug 2022, 15:08 |
| Q1 2022 | 77 | $1,302,462,000 | +$229,910,615 | -$125,983,429 | +$103,927,186 | TPTX, ERAS, DSGN, RXDX, GRNA | 13F-HR | 16 May 2022, 15:07 |
| Q4 2021 | 78 | $1,681,198,000 | +$151,567,511 | -$343,931,135 | -$192,363,624 | ERAS, TPTX, DSGN, RXDX, FMTX | 13F-HR | 14 Feb 2022, 15:19 |
| Q3 2021 | 88 | $2,461,043,000 | +$464,695,135 | -$347,712,525 | +$116,982,610 | ERAS, TPTX, AVIR, FMTX, RVMD | 13F-HR | 15 Nov 2021, 15:14 |
| Q2 2021 | 100 | $2,564,684,000 | +$486,933,806 | -$886,508,584 | -$399,574,778 | TPTX, AVIR, FMTX, BBIO, DSGN | 13F-HR | 16 Aug 2021, 15:13 |
| Q1 2021 | 115 | $3,472,944,000 | +$727,828,164 | -$418,702,335 | +$309,125,829 | AVIR, TPTX, DSGN, BBIO, FMTX | 13F-HR | 17 May 2021, 15:46 |
| Q4 2020 | 99 | $3,440,103,000 | +$1,012,081,078 | -$450,000,611 | +$562,080,467 | TPTX, AVIR, BBIO, FMTX, OLMA | 13F-HR | 16 Feb 2021, 15:21 |
| Q3 2020 | 87 | $2,273,248,000 | +$328,939,815 | -$448,990,409 | -$120,050,594 | TPTX, FMTX, RVMD, BBIO, CCXI | 13F-HR | 16 Nov 2020, 16:13 |
| Q2 2020 | 77 | $2,279,775,000 | +$364,271,352 | -$412,922,917 | -$48,651,565 | TPTX, FMTX, CCXI, PRNB, BBIO | 13F-HR | 14 Aug 2020, 15:17 |
| Q1 2020 | 68 | $1,755,344,000 | +$315,671,285 | -$284,878,604 | +$30,792,681 | TPTX, PRNB, BBIO, CCXI, XLRN | 13F-HR | 15 May 2020, 15:07 |